Suven Pharmaceuticals Limited (SUVENPHAR.BO)
INR 1222.9
(-1.92%)
INR 1222.9
(-1.92%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 649.96 Million INR | -7.6% |
| 2022 | 703.4 Million INR | -27.58% |
| 2021 | 971.27 Million INR | -32.1% |
| 2020 | 1.43 Billion INR | -23.18% |
| 2019 | 1.86 Billion INR | 124.9% |
| 2018 | 827.93 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 507.86 Million INR | 0.0% |
| 2023 FY | 649.96 Million INR | -7.6% |
| 2023 Q3 | 345 Million INR | -32.07% |
| 2023 Q4 | 649.96 Million INR | 88.4% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 703.4 Million INR | -27.58% |
| 2022 Q4 | 703.4 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 914.79 Million INR | 0.0% |
| 2021 Q4 | 971.27 Million INR | 0.0% |
| 2021 FY | 971.27 Million INR | -32.1% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 1.3 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 1.43 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 1.43 Billion INR | -23.18% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 1.53 Billion INR | 0.0% |
| 2019 Q4 | 1.86 Billion INR | 0.0% |
| 2019 FY | 1.86 Billion INR | 124.9% |
| 2019 Q1 | - INR | -100.0% |
| 2018 FY | 827.93 Million INR | 0.0% |
| 2018 Q4 | 827.93 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -84.23% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -3660.713% |
| Sigachi Industries Limited | 1.43 Billion INR | 54.564% |
| Bal Pharma Limited | 1.39 Billion INR | 53.457% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -291.036% |
| Medico Remedies Limited | 80.5 Million INR | -707.369% |
| Lasa Supergenerics Limited | 220.76 Million INR | -194.418% |
| Venus Remedies Limited | 413.3 Million INR | -57.262% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -6.29% |
| Alpa Laboratories Limited | 52.46 Million INR | -1138.853% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 89.773% |
| Shilpa Medicare Limited | 9.37 Billion INR | 93.066% |
| Aarti Drugs Limited | 5.64 Billion INR | 88.481% |
| Lupin Limited | 29.21 Billion INR | 97.775% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 99.022% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 91.918% |
| Windlas Biotech Limited | 36.41 Million INR | -1685.125% |
| Suven Life Sciences Limited | 7.09 Million INR | -9058.292% |
| Eris Lifesciences Limited | 27.81 Billion INR | 97.663% |
| Valiant Laboratories Limited | 767.08 Million INR | 15.268% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 82.79% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 93.574% |
| Ipca Laboratories Limited | 14.38 Billion INR | 95.481% |
| Bliss GVS Pharma Limited | 998.4 Million INR | 34.9% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 98.015% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 80.471% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | 68.627% |
| Laurus Labs Limited | 25.77 Billion INR | 97.478% |
| Piramal Pharma Limited | 47.1 Billion INR | 98.62% |
| Syncom Formulations (India) Limited | 724.86 Million INR | 10.333% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 98.384% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 87.334% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 94.72% |
| Unichem Laboratories Limited | 2.47 Billion INR | 73.74% |
| Sequent Scientific Limited | 4.87 Billion INR | 86.673% |
| Novartis India Limited | 69.7 Million INR | -832.516% |
| Wanbury Limited | 1.16 Billion INR | 44.202% |
| Wockhardt Limited | 23.56 Billion INR | 97.241% |
| Themis Medicare Limited | 957.92 Million INR | 32.149% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -626.948% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 98.226% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -279.032% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 96.753% |
| Divi's Laboratories Limited | 30 Million INR | -2066.547% |
| NATCO Pharma Limited | 3.71 Billion INR | 82.49% |
| Gufic Biosciences Limited | 3.32 Billion INR | 80.477% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -98.402% |
| Ind-Swift Limited | 10.13 Billion INR | 93.59% |
| Procter & Gamble Health Limited | 95.6 Million INR | -579.879% |
| FDC Limited | 205.18 Million INR | -216.77% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 66.398% |
| Granules India Limited | 13.15 Billion INR | 95.058% |
| Medicamen Biotech Limited | 308.17 Million INR | -110.909% |
| Alkem Laboratories Limited | 14.18 Billion INR | 95.418% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -1313.518% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -14708.931% |
| Brooks Laboratories Limited | 56.41 Million INR | -1052.03% |
| Megasoft Limited | 1.47 Billion INR | 55.799% |
| ZIM Laboratories Limited | 1.08 Billion INR | 40.274% |
| Strides Pharma Science Limited | 25.16 Billion INR | 97.418% |
| Neuland Laboratories Limited | 953.89 Million INR | 31.862% |
| Morepen Laboratories Limited | 289.99 Million INR | -124.132% |
| Hikal Limited | 8.17 Billion INR | 92.05% |
| Indoco Remedies Limited | 6.71 Billion INR | 90.327% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 77.214% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -105.383% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | 34.009% |
| Hester Biosciences Limited | 2.44 Billion INR | 73.403% |